TSE: 3446 - JTEC Corporation

Yield per half year: -28.38%
Dividend yield: 0.00%
Sector: Healthcare

JTEC Corporation

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
3/10
46.67 110.39 -57.72% 387.19 -87.95%
P/S 4.63 74.99 -93.82%
P/BV 3.45 70.27 -95.08%
P/FCF -169.56 79.2 -314.1%
Ev/Ebitda 21.1 16.85 25.21%
Ev/S 4.59 80.73 -94.32%
Ev/FCF -115.8 24.73 -568.31%
E/P 0.0148 -0.1555 -109.52%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
21.75 -144.44 -115.06% 11.55 +88.25%
ROE 7.71 -9.24 -183.45%
ROA 5.68 -9.69 -158.58%
ROIC 0 9.09 -100%
ROS 9.93 -211.07 -104.7%
ROCE 10.68 6.03 77.08%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.19 -1.04 -214.55% 0.9046 +31.99%
Nеt Debt/Ebitda -0.2019 12.51 -101.61%
Debt/Ratio 0.1463 0.1401 4.42%
Debt/Equity 0.0027 40.14 -99.99%
Debt/Net Income 2.62 -1.96 -233.44%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.65 -100% 0 0%
Number of years of dividend growth 0 1.28 -100%
DSI 0 0.7376 -100%
Average dividend growth 0 -18.51 -100%
Average percentage for 5 years 0 1.9 -100%
Average percentage for payments 56.54 32.83 72.24%
Difference from average difference in sector -2.65

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
9/10
95.18 87.09 9.29%
Growth impulse Ebitda in 5 years 242.35 69.14 250.52%
Growth impulse Net Income in 5 years 1117.02 31.67 3427.06%
Growth impulse FCF in 5 years -60.46 -20.71 191.94%
Growth impulse EPS in 5 years 1117.3 -36.16 -3189.88%
IP Score
5.1/10

Similar companies

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription